Today our research and development activities include the development of new and next-generation drug delivery technologies and the formulation of proprietary brand name, generic/non-branded products.
KV's approach to new-product development through application of delivery technology to known drugs is faster and far less risky than research of new molecular entities. Our drug delivery depth and breadth allows us to have 15 technological approaches in various stages of commercialization with decreased time to market compared to new molecular entities.
These technologies fall within four principal areas:
- SITE RELEASE® (bioadhesive)
- Tastemasking
- Quick-Dissolving Tablets
- Oral Controlled Release
Added to our expertise in drug delivery technologies is our commitment to state-of-the-art laboratory and manufacturing capabilities. Today, KV has more than 1,000,000 square feet of predominantly owned facility space. We have three shift operations producing products developed using our drug delivery technologies.
|